P45983 (MK08_HUMAN) Homo sapiens (Human)
Mitogen-activated protein kinase 8 UniProtKBInterProSTRINGInteractive Modelling
Available Structures
34 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Linear binding motifs for JNK and for calcineurin antagonistically control the nuclear shuttling of… |
Heteromer Q12968; | 1×ANP; 2×GOL; | ||||
| Assess | ||||||
| Linear binding motifs for JNK and for calcineurin antagonistically control the nuclear shuttling of… |
Heteromer Q12968; | 1×ANP; | ||||
| Assess | ||||||
| Crystal structure of JNK1 in complex with ATF2(19-58) |
Heteromer P15336; | 2×MG; 1×ANP; 1×ZN; | ||||
| Assess | ||||||
| Crystal structure of a cysteine-deficient mutant M7 in MAP kinase JNK1 |
Heteromer Q9UQF2; | 1×SO4; 1×TRS; | ||||
| Assess | ||||||
| Crystal structure of a cysteine-deficient mutant M3 in MAP kinase JNK1 |
Heteromer Q9UQF2; | 5×SO4; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of JNK1-alpha1 isoform complex with a biaryl tetrazol (A-82118) |
Heteromer Q9WVI9; | 1×46A; 2×SO4; | ||||
| Assess | ||||||
| Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1 |
Heteromer Q9UQF2; | 5×SO4; | ||||
| Assess | ||||||
| Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1 |
Heteromer Q9UQF2; | |||||
| Assess | ||||||
| Crystal structure of a cysteine-deficient mutant M5 in MAP kinase JNK1 |
Heteromer Q9UQF2; | 3×SO4; | ||||
| Assess | ||||||
| Discovery of Potent, Highly Selective, and Orally Bioavailable Pyridine Carboxamide C-jun NH2-termi… |
Heteromer Q9UQF2; | 2×SO4; 1×893; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1 |
Heteromer Q9UQF2; | 4×SO4; | ||||
| Assess | ||||||
| Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1 |
Heteromer Q9UQF2; | 1×SO4; | ||||
| Assess | ||||||
| Structural and functional analysis of quercetagetin, a natural JNK1 inhibitor |
Heteromer Q9WVI9; | 1×MYU; 7×SO4; 1×CL; | ||||
| Assess | ||||||
| Crystal Structure of JNK1-alpha1 isoform |
Heteromer Q9WVI9; | 2×SO4; | ||||
| Assess | ||||||
| Selective Aminopyridine-Based C-Jun N-terminal Kinase inhibitors with cellular activity |
Heteromer Q9UQF2; | 2×SO4; 1×877; | ||||
| Assess | ||||||
| Crystal structure of JNK1 bound to a MKK7 docking motif |
Heteromer O14733; | 1×ANP; 4×SO4; | ||||
| Assess | ||||||
| Crystal structure of JNK in complex with a regulator protein |
Heteromer Q9BY84; | 1×CL; | ||||
| Assess | ||||||
| Crystal structure of DARPin-DARPin rigid fusion, variant DD_D12_10_47 in complex JNK1a1 and JIP1 pe… |
Heteromer Q9WVI9; | |||||
| Assess | ||||||
| Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125 |
Heteromer Q9WVI9; | |||||
| Assess | ||||||
| Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125 |
Heteromer Q9WVI9; | 1×537; | ||||
| Assess | ||||||
| Crystal structure of DARPin-DARPin rigid fusion, variant DD_232_11_D12 in complex JNK1a1 and JIP1 p… |
Heteromer Q9UQF2; | 7×SO4; 1×ADN; | ||||
| Assess | ||||||
| Pyrazoloquinolones as Novel, Selective JNK1 inhibitors |
Heteromer Q9UQF2; | 2×SO4; 1×73Q; | ||||
| Assess | ||||||
| Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(3-Methanesulfonyl-propoxy)-inda… |
Heteromer Q9UQF2; | 1×1BK; | ||||
| Assess | ||||||
| Crystal structure of JNK1beta-JIP in complex with an azaquinolone inhbitor |
Heteromer Q9UQF2; | 1×0NR; | ||||
| Assess | ||||||
| Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(4-Methanesulfonyl-piperidin-1-y… |
Heteromer Q9UQF2; | 1×1J2; | ||||
| Assess | ||||||
| Crystal structure of JNK1 in complex with JIP1 peptide and 4-(4-Indazol-1-yl-pyrimidin-2-ylamino)-c… |
Heteromer Q9UQF2; | 1×1BJ; | ||||
| Assess | ||||||
| Crystal structure of JNK1 in complex with JIP1 peptide and 7-Fluoro-3-[4-(2-hydroxy-ethanesulfonyl)… |
Heteromer Q9UQF2; | 1×G1W; | ||||
| Assess | ||||||
| Structure of human JNK1 in complex with SCH772984 and the AMPPNP-hydrolysed triphosphate revealing … | monomer | 22×EDO; 1×EPE; 1×38Z; 1×ANP; 1×MG; | ||||
| Assess | ||||||
| Jnk1 complexed with a bis-anilino-pyrrolopyrimidine inhibitor. | monomer | 1×GS7; | ||||
| Assess | ||||||
| Human Jnk1alpha kinase with 4-phenyl-7-azaindole IKK2 inhibitor. | monomer | 1×AQ2; 2×SO4; | ||||
| Assess | ||||||
| The Crystal Structure of JNK1 from Biortus. | monomer | 1×Y4O; 2×GOL; 1×EDO; | ||||
| Assess | ||||||
| Novel 4-anilinopyrimidines as potent JNK1 Inhibitors | monomer | 2×SO4; 1×859; | ||||
| Assess | ||||||
| Co-crystal Structure of JNK1 and AX13587 | monomer | 1×1V5; | ||||
| Assess | ||||||
| JNK1 in complex with inhibitor | monomer | 4×SO4; 1×CFK; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7yl1.1.A | monomer | 0.84 | 1×J6F; | 91.08 | ||
| Assess | ||||||
5 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 7yl1.1.A | monomer | 0.84 | 1×J6F; | 92.59 | |
| Assess | ||||||
| Isoform 3 | 7yl1.1.A | monomer | 0.84 | 1×J6F; | 91.27 | |
| Assess | ||||||
| Isoform 4 | 7yl1.1.A | monomer | 0.84 | 1×J6F; | 89.91 | |
| Assess | ||||||
| Isoform 5 | 2xs0.1.A | monomer | 0.80 | 97.40 | ||
| Assess | ||||||
| Isoform 5 | 3npc.1.A | monomer | 0.64 | 76.74 | ||
| Assess | ||||||